CHIESI SAS
🇫🇷France
Clinical Trials
3
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence
Not yet recruiting
- Conditions
- Chronic Renal Disease
- Interventions
- Drug: Life-Cycle Pharma TacrolimusProcedure: Kidney transplantation
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Chiesi SAS
- Target Recruit Count
- 165
- Registration Number
- NCT06960824
- Locations
- 🇫🇷
Chru Tours, Tours, France
Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study
Recruiting
- Conditions
- COPD
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Chiesi SAS
- Target Recruit Count
- 500
- Registration Number
- NCT05948891
- Locations
- 🇫🇷
Pitié-Salpêtrière Hospital, Paris, France
A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes
Recruiting
- Conditions
- ASTHMA
- First Posted Date
- 2023-02-15
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Chiesi SAS
- Target Recruit Count
- 300
- Registration Number
- NCT05728749
- Locations
- 🇫🇷
ChiesiFrance, Bois-Colombes, France
News
No news found